Result of Meeting
25 April 2005 - 5:59PM
UK Regulatory
RNS Number:4886L
Bioscience Inv Trust PLC
25 April 2005
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES,
CANADA, AUSTRALIA, THE REPUBLIC OF IRELAND OR JAPAN.
The Bioscience Investment Trust plc
Result of the First Extraordinary General Meeting of the Company relating to the
scheme of reconstruction
The Board of The Bioscience Investment Trust plc (the "Company") is pleased to
announce that at the Extraordinary General Meeting of the Company held today, 25
April 2005, the resolution approving the scheme of reconstruction of the Company
(the "Scheme") put to the meeting was duly passed.
The last date for receiving Forms of Elections was 22 April 2005. The results of
the Elections are shown in the table below:
Option No. of shares
Schroder Medical Discovery Fund 3,620,796
Cash 41,095,048
Total 44,715,844
A further Extraordinary General Meeting will be held on 13 May 2005 at 11.00am
at which resolutions will be proposed for the winding up of the Company, the
appointment of liquidators, and the grant of appropriate powers to the
liquidators. The Scheme will not become effective until these resolutions are
passed. Shareholder entitlements pursuant to the Scheme will be announced by the
Company in due course following the second extraordinary general meeting
assuming that the Scheme becomes effective.
Expected timetable
Date 2005 Time Event
28 April 7.30am Dealings in Reclassified Shares commence and register of holders
of Reclassified Shares opened
11 May 11.00am Latest time for receipt of forms of proxy for the Second
Extraordinary General Meeting
12 May 6.00pm Register of holders of Reclassified Shares closed
11.59pm Calculation Date to value the assets of the Company and
determine entitlements under the Scheme
13 May 7.30am Suspension of listing of Reclassified Shares
11.00am Second Extraordinary General Meeting
12.00 noon Calculation of Fund Issue Price
Effective Date of the Scheme
Units issued
Week commencing 16 Confirmation letters dispatched in respect of Units
May
Distribution of cash entitlements to Shareholders who elect for
the Cash Option under the Scheme
Enquiries:
Robin Stoakley 0207 658 3567
Schroder Investment Management Limited
John Spedding 0207 658 3206
Schroder Investment Management Limited
Angus Gordon Lennox 020 7588 2828
JPMorgan Cazenove Limited
END
This information is provided by RNS
The company news service from the London Stock Exchange
END
REGEELFLEZBEBBE
Bioscience Trust (LSE:BSI)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
Bioscience Trust (LSE:BSI)
Historical Stock Chart
Von Jun 2023 bis Jun 2024
Echtzeit-Nachrichten über Bioscience Inv (Londoner Börse): 0 Nachrichtenartikel
Weitere Bioscience Inv Tst News-Artikel